Total Funding
34
Total FundingSeed raised
Growth Score in past quarter
pts
Heat Score 34 in past quarter
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
89079
Biorez is a medicine company focused on the development of tendon and ligament healing.
- Jeffrey A. Baird: Chief Financial OfficerPast Role: CAS Medical Systems, CFO, Secretary
- Robert Poggie: Regulatory and R&D
About the Company
Biorez is a medical device company whose aim is to apply its patented and proprietary technology comprised of PLLA, a degradable polymer, in orthopedic implant devices for regeneration and augmentation of soft tissue. In addition to the L-C Ligament®, Biorez has also developed a suite of associated products, including the biorez GRAFT™, a FDA
510(k)-cleared innovative device for soft tissue augmentation of the rotator cuff in the United States.

